Press release

Showing 15 posts of 581 posts found.

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

January 14, 2025
Switzerland, pharmapack, report

 Pharmapack Europe: ‘Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and …

NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer

December 19, 2024
ESR1, Menari Group, NICE, breast cancer, drug

Elacestrant is the first tailored treatment for certain people with oestrogen receptor (ER)-positive HER2-negative locally advanced and metastatic breast cancer …

MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain

December 16, 2024
LEO Pharma, eczema

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain for Anzupgo® (delgocitinib) 20mg/g cream …

Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

December 13, 2024
CPHI Milan, CPhI, networking

13 December 2024 – Amsterdam, the Netherlands –  CPHI Milan – the world’s largest pharma event – hosted last month …

Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company

December 12, 2024
Corporate, Deep Science Ventures, General Inception, fibrosis, venture

12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and …

NICE RECOMMENDS LILLY’S TIRZEPATIDE (MOUNJARO ®▼) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE

December 10, 2024
Mounjaro, NICE, lilly, weight-loss

BASINGSTOKE, 5th December 2024 – Eli Lilly and Company announced today that the National Institute for Health and Care Excellence …

Ceryx Medical Initiates First-In-Human Study of the Cysoniâ„¢ RSA Pacemaker

November 21, 2024
Ceryx Medical, Devices, biotech

Ceryx’s Cysoni pacing technology is designed to provide superior therapeutic outcomes for Heart Failure patients by improving cardiac output using …

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

November 20, 2024
AMR Week, Glox Therapeutics, antimicrobial resistance

Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding …

Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List

November 19, 2024
Chiesi, Corporate, best workplace

Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best …

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

November 18, 2024
barinthius Bio

Eight participants achieved HBsAg loss at any time. Two participants met criteria for functional cure. Two participants who discontinued NUC …

CMS commences formal review for Topical Oxygen Therapy coverage

November 11, 2024
Wound Healing, topical oxygen therapy, wound care

11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention …

FlyPharma Vienna 2024: An Event to Remember!

November 4, 2024
Corporate, FlyPharma 2024, Samedan, event

Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a …

Valneva Scotland supports local cancer charity Team Jak Foundation 

October 31, 2024
Support Services Oncology, Scotland, Valneva Scotland, cancer charity, paediarics, vaccines

Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team Jak, helping towards the organisation’s …

From molecule to market and beyond: Uniphar announces extended global commercialization platform

October 25, 2024
CRO, UniPhar, cell and gene

22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …

The Gateway to Local Adoption Series

Latest content



Pace appoints Ken Beyer as CEO

December 10, 2025